Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

This is a Ph 2, randomized, double-blind, placebo-controlled global multicenter study to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of PIPE-791 in participants with a diagnosis of Idiopathic Pulmonary Fibrosis (IPF) with or without background treatment.

Participants needed: 324
Trial details
Phase: Phase 2Age: 40+Biological sex: AllType: InterventionalSponsor: Contineum TherapeuticsUpdated: Jul 13, 2026Locations: 49
Eligibility criteria

Male or female ≥ 40 years of age at the time of Randomization. [+3]

Those with a history of interstitial lung disease (ILD) other than IPF are not e... [+4]

Read more
Status: Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

This is a Ph 2, randomized, double-blind, placebo-controlled global multicenter study to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of PIPE-791 in participants with a diagnosis of Idiopathic Pulmonary Fibrosis (IPF) with or without background treatment.

Participants needed: 324
Trial details
Phase: Phase 2Age: 40+Biological sex: AllType: InterventionalSponsor: Contineum TherapeuticsUpdated: Jul 1, 2026Locations: 47
Eligibility criteria

Male or female ≥ 40 years of age at the time of Randomization. [+3]

Those with a history of interstitial lung disease (ILD) other than IPF are not e... [+4]

Read more